{'text': 'Sanofi and MannKind announce global licensing agreement for Afrezza® (insulin human) rapid-acting inhaled insulin', 'publisher': {'href': 'https://www.drugtargetreview.com', 'title': 'Drug Target Review'}, 'created_at': 'Tue, 12 Aug 2014 07:00:00 GMT', 'description': 'Sanofi and MannKind announce global licensing agreement for Afrezza® (insulin human) rapid-acting inhaled insulin  Drug Target Review', 'url': 'https://news.google.com/rss/articles/CBMi3wFBVV95cUxPeTk3VkFnbXZHdWpaN1E3Wkswa0JZVkJZRXVFZDQxWms4RnZIYUltWkh1YlNKb2FabU1qZm1LdFU4UUJYVHZsRXdOX1E4SjRPUUc2aW5CZkJiQlpneEkyNVV4bGVPRElYdnRKT091cTROVGE5dHBnYjhkcHJrdjM0Y1JyTmNJX2YtSkZwWmk2U3I2aHNpQTFzNzVFR3hUR1dvM2U2S3Y4ZS1maTVrZmFnWEZTT0M5VVNFcUlwdm5HUG1CUVpNblpRT0VHR0FwMGZIYmIwY2p2cGk5V1dRQURz?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "USFDA reports serious violations at IPCA's Ratlam facility", 'publisher': {'href': 'https://www.business-standard.com', 'title': 'Business Standard'}, 'created_at': 'Tue, 12 Aug 2014 07:00:00 GMT', 'description': "USFDA reports serious violations at IPCA's Ratlam facility  Business Standard", 'url': 'https://news.google.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?oc=5&hl=en-US&gl=US&ceid=US:en'}
